Procept Biorobotics Corp expected to post a loss of 49 cents a share - Earnings Preview

PROCEPT BioRobotics

25/10/2024 14:08

* Procept Biorobotics Corp  PRCT.OQ   PRCT.O  is expected
to show
a rise in quarterly revenue when it reports  results on October
28 for the period ending September 30 2024
    * The San Jose California-based  company is expected to
report a
51.5% increase in revenue to $53.183 million from $35.1 million
a year ago, according to the mean estimate from 8 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Procept Biorobotics Corp
is
for a loss of 49 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Procept
Biorobotics Corp is 92.00​, above​ its last closing price
of $66.83. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.52       -0.52      -0.50     Beat    4.3
 Mar. 31 2024  -0.55       -0.56      -0.51     Beat    8.2
 Jan. 1 0001   -0.44       -0.44      -0.54     Missed  -23​
 Jan. 1 0001   -0.51       -0.51      -0.51     Met     0.9
 ​​Jun.        -0.57       -0.57      -0.56     Beat    2
 30 2023                                                
 Jan. 1 0001   -0.58       -0.58      -0.63     Missed  -8.4​
 Dec. 31 2022  -0.55       -0.54      -0.56     Missed  -2.9
 Sep. 30 2022  -0.48       -0.48      -0.51     Missed  -6
 This summary was machine generated October 25 at 13:08 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)